Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
- P. Malfertheiner, F. Mégraud, E. El-Omar
- MedicineGut
- 5 October 2016
TLDR
European consensus conference on faecal microbiota transplantation in clinical practice
- G. Cammarota, G. Ianiro, A. Gasbarrini
- MedicineGut
- 13 January 2017
TLDR
What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases
- E. Rinninella, P. Raoul, M. C. Mele
- Biology, MedicineMicroorganisms
- 1 January 2019
TLDR
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.
- M. Zocco, E. di Stasio, A. Gasbarrini
- MedicineJournal of hepatology
- 1 October 2009
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease
- F. Ponziani, S. Bhoori, V. Mazzaferro
- Medicine, BiologyHepatology
- 10 July 2018
TLDR
Methodology and Indications of H2‐Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference
- A. Gasbarrini, G. Corazza, A. Tursi
- MedicineAlimentary pharmacology & therapeutics
- 30 March 2009
TLDR
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection
- G. Cammarota, L. Masucci, A. Gasbarrini
- Medicine, BiologyAlimentary pharmacology & therapeutics
- 1 May 2015
Faecal microbiota transplantation (FMT) from healthy donors is considered an effective treatment against recurrent Clostridium difficile infection.
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori
- A. Gasbarrini, F. Franceschi, R. Tartaglione, R. Landolfi, P. Pola, G. Gasbarrini
- Medicine, BiologyThe Lancet
- 12 September 1998
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
- M. Zocco, L. Z. Dal Verme, A. Gasbarrini
- MedicineAlimentary pharmacology & therapeutics
- 1 June 2006
Aminosalicylates are the mainstay of therapy to prevent relapse of quiescent ulcerative colitis. The rationale for using probiotics is based on the evidence implicating intestinal bacteria in the…
...
...